Massive blood disorder registry aims to transform care

NCT ID NCT06820515

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is a large registry that collects health information from up to 200,000 people with blood disorders such as hemophilia, thrombosis, and sickle cell disease. Participants are seen at Hemophilia Treatment Centers across the U.S. The goal is to gather real-world data to help doctors, researchers, and policymakers improve treatment and public health reporting. No experimental treatments are given; it is purely observational.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this registry could provide insights that lead to better treatments and care guidelines for people with blood disorders.
What could go wrong
This is an observational registry, not a treatment trial. It collects data but does not test any intervention, so direct benefits to participants are unlikely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLEEDING DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • American Thrombosis and Hemostasis Network

    RECRUITING

    Hickory, North Carolina, 28601, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.